{
    "name": "Pharmacy certification requirements",
    "number": "5",
    "text": "(a)\u00a0 A high managerial agent acting on behalf of the pharmacy shall cause to be filed, with the designated state agency responsible for administering the medicaid program, a certified transaction account detailing every transaction under this chapter.\u00a0 The certified transaction account shall include the following information relative to each drug returned:\n\u00a0\u00a0\u00a0\u00a0 (1)\u00a0 If the transaction involved medicaid:\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 The medicaid provider number of the pharmacy;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (B)\u00a0 The medicaid provider number of the institutional facility;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (C)\u00a0 The name and beneficiary identification number of the medicaid beneficiary to whom the returned drug was originally prescribed;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (D)\u00a0 The name and provider number of the physician who originally prescribed the drug;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (E)\u00a0 The NDC number appearing on the original prescription;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (F)\u00a0 The lot number, if available;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (G)\u00a0 The medicaid claim number of the original prescription;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (H)\u00a0 The medicaid transaction number of the credit for the returned drug; and\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (I)\u00a0 The reason for the return of the drug;\n\u00a0\u00a0\u00a0\u00a0 (2)\u00a0 If the transaction involves the federal medicare program:\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (A)\u00a0 A copy of the 204-claim form, or its then existing equivalent, detailing the original transaction;\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (B)\u00a0 Documentation of the corresponding credit to the federal medicare program; and\n\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 (C)\u00a0 Any other information required by the federal administrators of the medicare program; and\n\u00a0\u00a0\u00a0\u00a0 (3)\u00a0 If the transaction involves a private pay patient in an institutional facility, a certification that the payer was properly credited.\n\u00a0\u00a0\u00a0\u00a0 (b)\u00a0 The same agent who filed the certification under this section shall concurrently certify that no drugs, other than those detailed in the transaction account, were returned to the pharmacy during that quarter.\u00a0 The agent shall further certify that all drugs accepted for return were either safe for resale, or were disposed of in accordance with the laws of this State and federal laws governing disposal of medication.\n\u00a0\u00a0\u00a0\u00a0 (c)\u00a0 The quarterly certifications shall be filed no later than April 1, July 1, October 1, and December 31 of each calendar year.\n\u00a0\u00a0\u00a0\u00a0 (d)\u00a0 For purposes of this section, \"high managerial agent\" has the same meaning as provided in section 702-229(3). [L 2004, c 190, pt of \u00a72]"
}